Kanal Singh, MD, MPH

Clinical Fellow
The National Institute of Allergy and Infectious Diseases, National Institutes of Health
Bethesda, MD, United States

Dr. Singh is a senior clinical fellow in Infectious Diseases at the National Institutes of Health. He completed his undergraduate education at University of California Berkeley, received his MD at the University of California Irvine School of Medicine, completed residency in Internal Medicine at the University of California Davis, and obtained his MPH from the Johns Hopkins Bloomberg School of Public Health. He currently serves on the Government Support Team for the NIH COVID-19 Treatment Guidelines Panel. His current research has focused on clinical and translational studies for HIV, COVID-19, and other emerging infectious diseases.

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 789 - Viral and Immunologic biomarkers of COVID-19 improve risk stratification and identify patients most likely to benefit from therapy with remdesivir

  Thursday, October 20, 2022
  4:15 PM – 4:30 PM US ET